This cooperative agreement from the Food and Drug Administration supports activities related to analgesics, anesthetics, and addiction clinical trials. The opportunity allows clinical trials and has a deadline of May 19, 2026. Specific eligibility and funding amount details are not provided.
Eligibility details are not specified in the grant listing. Contact the funding organization for requirements.
